Falk Gastro Review Journal
This page provides access to all FGR publications selected from international medical journals since mid-2022. You may browse the 1000+ articles by using one of the organ- or indication-related filters below or select all articles from a specific issue. If you are looking for ta specific journal edition, please have a look at the FGR print version.
Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States
J Hepatol. 2025;83(1):21-30
The prevalence and rate of undiagnosed celiac disease in an adult general population, the Trøndelag Health Study, Norway
Clin Gastroenterol Hepatol. 2025;23(7):1143-1151
Older adults with celiac disease are at increased risk of frailty: A nationwide cohort study
Am J Gastroenterol. 2025;120(7):1636-1644
Risk of gastric adenocarcinoma after eradication of Helicobacter pylori
Gastroenterology. 2025;169(2):244-250.e1
Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: A multicentre prospective study
Gut. 2025;74(9):1410-1418
Helicobacter pylori antibiotic resistance: A global challenge in search of solutions Background: Helicobacter pylori resistance to antibiotics commonly used in eradication regimens is increasing dramatically in many locations; new strategies are needed to manage this infectious disease.
Gut. 2025;74(10):1561-1570
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): A double-blind, placebo-controlled, randomised, phase 2 trial
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):622-633
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician’s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): A randomised, open-label, phase 2 trial
Lancet. 2025;405(10494):2049-2060
Perioperative durvalumab in gastric and gastroesophageal junction cancer
N Engl J Med. 2025;393(3):217-230